Home Newsfeeds Jefferies Downgrades Applied Molecular to Hold

Jefferies Downgrades Applied Molecular to Hold

Jefferies analyst Chris Howerton downgrades Applied Molecular (NASDAQ:AMTI) from Buy to Hold.

byBenzinga Newsdesk

July 7, 2022

1 minute read

Jefferies analyst Chris Howerton downgrades Applied Molecular (NASDAQ:AMTI) from Buy to Hold.

GTA VI Trailer: What Does Tom Petty’s Song Mean For The Plot?

By Franca Quarneti

December 6, 5:34 PM

The release of Take-Two Interactive Software Inc's (NASDAQ: TTWO) Grand Theft Auto 6 (GTA 6) trailer sparked fervent speculation among fans, particularly about the significance of the featured song,

TTWO

Canaccord Genuity Maintains Buy on AtriCure, Lowers Price Target to $74

By Benzinga Newsdesk

February 22, 9:32 AM

Canaccord Genuity analyst William Plovanic maintains AtriCure (NASDAQ:ATRC) with a Buy and lowers the price target from $81 to $74.

ATRC

Goldman Sachs Reportedly Eyes Fresh Hires Just Days After Massive Layoffs At Citigroup – Divergent Strategies?

By Nabaparna Bhattacharya

January 18, 12:59 PM

Goldman Sachs Group is actively recruiting for its asset and wealth management divisions, aiming to fortify these sectors after a successful 23% revenue surge in Q4, exceeding expectations. The move follows a period of restraint during which the bank cut 6.5% of its workforce.

IPOs
News

Marex Group plc Announces Launch Of Initial Public Offering Of 15,384,615 Ordinary Shares At A Price Between $18-$21 Per Share

By Benzinga Newsdesk

April 15, 9:23 AM

Marex Group plc ("Marex"), the diversified global financial services platform, today announces that it has launched the initial public offering (the "IPO") of its ordinary shares. A total of 15,384,615 ordinary shares

MRX

Jefferies Downgrades Applied Molecular to Hold

Related Posts

GTA VI Trailer: What Does Tom Petty’s Song Mean For The Plot?

Canaccord Genuity Maintains Buy on AtriCure, Lowers Price Target to $74

Goldman Sachs Reportedly Eyes Fresh Hires Just Days After Massive Layoffs At Citigroup – Divergent Strategies?

Marex Group plc Announces Launch Of Initial Public Offering Of 15,384,615 Ordinary Shares At A Price Between $18-$21 Per Share